Clinical trials
Pulmonary Embolism clinical trials
Below are recruiting pulmonary embolism clinical trials, each written for real people, not researchers. We’re tracking 105 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06362928Recruiting
Testing a device to remove lung blood clots
This trial tests a new device (the Akura Thrombectomy System) that removes blood clots from the lungs in people with a sudden, severe pulmonary embolism. It aims to see if the device is safe and effective at improving blood flow and heart function.
GrazAges 18–90 - NCT06672510Recruiting
Study of a clot-removal device for acute pulmonary embolism
This trial tests a new device that removes blood clots from the lungs through a small tube. It is for people with a recent pulmonary embolism who have slightly strained hearts but stable blood pressure.
Thousand Oaks, CaliforniaAges 18 years+ - NCT07190079Recruiting
New way to diagnose blood clots in the lungs using saline
This study tests a new method using a saline solution and a special imaging belt to quickly diagnose pulmonary embolism (a blood clot in the lungs) in people with acute breathing problems. If successful, it could provide a faster, safer alternative to standard CT scans.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07029841Recruiting
Catheter therapy study for acute pulmonary embolism patients
This study follows patients in Hong Kong who are treated with catheter-based therapy for acute pulmonary embolism. It aims to understand how well this treatment works.
Hong Kong, Hong KongAges 18 years+ - NCT07724197Recruiting
Using a new imaging test to find blood clots in the lungs
This study tests a new, non-invasive imaging method called pulsatile electrical impedance tomography (EIT) to help diagnose and monitor acute pulmonary embolism (blood clots in the lungs). It may provide a faster or safer way to detect clots compared to standard CT scans, especially for patients who cannot have contrast dye.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06433011Recruiting
New clot-busting method for pulmonary embolism
This study tests a new way of delivering a clot-dissolving medicine for people with a serious but not immediately life-threatening pulmonary embolism. The goal is to see if giving the medicine as small bursts directly into the clot can help the heart recover faster.
Scottsdale, ArizonaAges Any age - NCT04263038RecruitingPhase 4
Watchful waiting versus blood thinners for small lung clots
This trial compares close monitoring (“watch and wait”) versus taking the blood thinner rivaroxaban in people with a small type of lung blood clot. It aims to find out whether low-risk patients can safely avoid or reduce anticoagulation while still staying healthy.
Woluwe-Saint-Lambert, Brussels CapitalAges 18 years+ - NCT04355975Recruiting
Study follow-up outcomes after a lung blood clot
This trial looks at how people do after an acute pulmonary embolism (a blood clot in the lungs). It aims to understand real-world outcomes over follow-up and may help improve how care teams track patients after treatment.
Bern, Canton of BernAges Any age - NCT04711746Recruiting
Clonal blood changes after certain lung blood clots
This study looks at whether a specific kind of blood-cell change (“clonal hematopoiesis”) is linked to a lung blood clot (pulmonary embolism) that happened without a clear trigger. It compares people with unprovoked clots to people with provoked clots, after checking for inherited clotting risk factors.
AmiensAges 18–65 - NCT05015153Recruiting
Rehab after blood clot in the lungs to improve daily life
This study looks at whether pulmonary rehabilitation (a supervised exercise and support program for lung recovery) improves quality of life after a lung blood clot. It focuses on people who have ongoing breathing-related limits after treatment with blood thinners.
Brest, FranceAges 18 years+ - NCT05050617Recruiting
Ultrasound in the ER to predict risks in pulmonary embolism
This trial checks whether a bedside ultrasound done in the emergency room can help predict which people with an acute pulmonary embolism are more likely to have bad outcomes. If you qualify, your care team will compare ultrasound findings with your later results to see if it can guide treatment decisions sooner.
York, PennsylvaniaAges 18 years+ - NCT05103670Recruiting
PET/CT lung scan to assess recovery after pulmonary embolism
This study uses a special scan (PET/CT) and an inhaled/linked tracer to measure how well air and blood flow work in different lung areas after a pulmonary embolism. It’s meant to better understand regional lung function and how rehabilitation may help some people recover.
BrestAges 18–99 - NCT06143969Recruiting
Ultrasound-guided clot-dissolving treatment for intermediate-high risk pulmonary embolism
This trial tests a treatment that uses ultrasound to guide a thin tube (catheter) to deliver clot-busting medicine directly into the blood clot in your lung. It may be an option for people whose clot is serious but not yet causing shock, and who have symptoms that started within the last two weeks.
Milan, ItaliaAges 18 years+ - NCT06166329Recruiting
Chair lift test for pulmonary embolism prognosis
This study checks if a simple chair lift test can help predict recovery in patients with a blood clot in the lung (pulmonary embolism) who are not critically ill. It aims to find out if this test can help doctors decide on the best follow-up care.
RouenAges 18 years+ - NCT06348459Recruiting
Catheter treatment for severe pulmonary embolism
This study looks at how well a catheter (a thin tube) works to treat a serious type of blood clot in the lungs. It is for people who have a large clot that is causing problems like fast heart rate or low blood pressure.
Madrid, MadridAges 18 years+ - NCT06362746RecruitingPhase 3
Staphylokinase for intermediate high-risk pulmonary embolism
This trial tests a new drug, staphylokinase, to see if it can break up blood clots in the lungs in people with a moderate-high risk pulmonary embolism. The goal is to improve blood flow and reduce the chance of complications.
Barnaul, Altayskiy KrayAges 18 years+ - NCT06528418Recruiting
Breath test to find lung diseases
This study uses a simple breath test to detect different lung diseases. By analyzing the chemicals in your breath, researchers hope to find a faster, non-invasive way to diagnose lung conditions. It may be an option if you have a known lung disease and have a recent CT scan.
Guangzhou, GuangdongAges 18–100 - NCT06672081Recruiting
Early catheter treatment for high-risk pulmonary embolism
This study tests whether using a catheter (a thin tube) to remove blood clots from the lungs early can help people with a severe, life-threatening pulmonary embolism. It is for patients who are in shock or have had a cardiac arrest due to a large clot.
Bad KrozingenAges 18 years+ - NCT06697314Recruiting
Clot removal for acute pulmonary embolism with heart strain
This study tests a new device (AlphaVac) that removes blood clots from the lungs using a thin tube inserted through a vein. It may be an option for people with acute pulmonary embolism who have signs of heart strain or low blood pressure.
PoznanAges 18 years+ - NCT07245927Recruiting
Staphylokinase for massive pulmonary embolism with shock
This trial tests a single injection of a clot-busting drug called staphylokinase for people with a massive pulmonary embolism that is causing shock or very low blood pressure. It aims to see how well the drug works in this emergency situation.
BelgorodAges 18 years+ - NCT06912009Recruiting
How long to treat blood clots in the lungs
This trial looks at how long people need blood-thinning medicine after a serious blood clot in the lungs. It might help doctors find the best treatment length for each person.
StrasbourgAges 18 years+ - NCT06946732Recruiting
Acostream for high-risk and intermediate-risk pulmonary embolism
This trial is testing a device (called the Acostream) to break up blood clots in the lungs for people with serious pulmonary embolism who cannot receive standard clot-busting drugs or surgery. It may be an option if you have high-risk or intermediate-risk PE and are between 18 and 85.
Shanghai, Shanghai MunicipalityAges 18–85 - NCT07003646Recruiting
Treating acute pulmonary embolism with clot-dissolving or catheter procedures
This study looks at how well different treatments work for a blood clot in the lung (pulmonary embolism). It includes people who are getting or have already gotten a clot-dissolving medicine or a catheter procedure to remove the clot.
AarhusAges 18 years+ - NCT07431229Recruiting
Nitrates for moderate-to-high risk pulmonary embolism
This trial tests whether a common food additive (nitrates) can help your heart recover faster when you have a serious pulmonary embolism. It is for people with a recent clot and signs of heart strain, but who are not on specific blood thinners or other nitrate medicines.
StockholmAges 18 years+
Hear when a new Pulmonary Embolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Pulmonary Embolism trials by city
Studies with a site in or near these metro areas.
Pulmonary Embolism trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for pulmonary embolism?
- Yes. Clin2 currently lists 105 recruiting pulmonary embolism studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pulmonary embolism trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pulmonary embolism trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.